Home Articles List Article Information
ALEXMED ePosters
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Kozou, H., Amin, N., AbdElSalam, M., Mahfouz, A. (2024). THE CORRELATION BETWEEN GLYCATED HEMOGLOBIN LEVEL AND HEARING LOSS IN SUBJECTS WITH TYPE 2 DIABETES. ALEXMED ePosters, 6(2), 45-46. doi: 10.21608/alexpo.2024.296679.1860
Hesham Saad Kozou; Noha Amin; Mayada ElSherif AbdElSalam; Aya Fathey El Sayed Mahfouz. "THE CORRELATION BETWEEN GLYCATED HEMOGLOBIN LEVEL AND HEARING LOSS IN SUBJECTS WITH TYPE 2 DIABETES". ALEXMED ePosters, 6, 2, 2024, 45-46. doi: 10.21608/alexpo.2024.296679.1860
Kozou, H., Amin, N., AbdElSalam, M., Mahfouz, A. (2024). 'THE CORRELATION BETWEEN GLYCATED HEMOGLOBIN LEVEL AND HEARING LOSS IN SUBJECTS WITH TYPE 2 DIABETES', ALEXMED ePosters, 6(2), pp. 45-46. doi: 10.21608/alexpo.2024.296679.1860
Kozou, H., Amin, N., AbdElSalam, M., Mahfouz, A. THE CORRELATION BETWEEN GLYCATED HEMOGLOBIN LEVEL AND HEARING LOSS IN SUBJECTS WITH TYPE 2 DIABETES. ALEXMED ePosters, 2024; 6(2): 45-46. doi: 10.21608/alexpo.2024.296679.1860

THE CORRELATION BETWEEN GLYCATED HEMOGLOBIN LEVEL AND HEARING LOSS IN SUBJECTS WITH TYPE 2 DIABETES

Article 1, Volume 6, Issue 2, April 2024, Page 45-46  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2024.296679.1860
View on SCiNiTO View on SCiNiTO
Authors
Hesham Saad Kozou1; Noha Amin2; Mayada ElSherif AbdElSalam1; Aya Fathey El Sayed Mahfouz email 1
1Department of Otorhinolaryngology, Audiology Unit, Faculty of Medicine, Alexandria University
2Department of Internal Medicine, Faculty of Medicine, Alexandria University
Abstract
According to the World Health Organization (WHO) data, about 5% of the world population experience a hearing loss problem. Isolation, melancholy, and cognitive decline are all factors that might exacerbate when someone has hearing trouble.
Diabetes mellitus has been implicated as a risk factor for hearing loss. Hearing loss is approximately twice as common in adults with diabetes as in those who do not have the disease. The prevalence of hearing loss in type 2 diabetic patients varies from 34.4 to 60.2%, according to different studies. The pathology of hearing loss in diabetics remains unclear. Microangiopathy, auditory nerve demyelination, spiral ganglion cell loss, and organ of Corti atrophic changes are the suspected causes of diabetes-induced hearing loss.
Serum glycated hemoglobin (HbA1c) level is the main biomarker for long-term glycemic control in individuals with diabetes. The serum HbA1c level evaluates and monitors the effectiveness of treatment given over a previous period, usually within the past two or three months.
Strong evidence supports that timely diagnosis and use of hearing aids can significantly improve quality of life, improve communication, and reduce depression and the rate of cognitive decline in patients with hearing loss. This makes it important to identify patients with T2DM who are at greater risk of developing hearing loss.
Keywords
HEARING LOSS IN SUBJECTS WITH TYPE 2 DIABETES; GLYCATED HEMOGLOBIN LEVEL AND HEARING LOSS; extended high frequencies assesment in diabetics
Supplementary Files
Statistics
Article View: 58